Loading
Loading
Growth Hormone & Secretagogues · 10mg
Janoshik-tested · 10 vials per kit
GHRP-6 is a synthetic hexapeptide growth hormone secretagogue studied in preclinical research for its GH-releasing and ghrelin-mimetic properties. Research has examined its potential to stimulate pulsatile GH secretion, increase appetite through hypothalamic action, support anabolic processes, and exhibit tissue-protective effects including gastric mucosal protection in animal models.
≥98%
Purity
Lyophilised
Format
2–3 wks
Arrival
Don't want to wait 3 weeks?
Check local stock — weekday same/next-day delivery available.
Need to work out your dose?
Use our reconstitution calculator — syringe units in seconds.
Research Use Only — Disclaimer
This product is intended solely as a research chemical for laboratory and scientific study purposes only. It is not approved by the TGA or any regulatory body for human or animal consumption, therapeutic use, or clinical application. The information provided on this website is for educational purposes only. Handling must be limited to suitably qualified professionals operating within applicable laws and regulations. This product is not classified as a drug, food, cosmetic, or medicinal product and must not be used or labelled as such. By purchasing, you confirm you are a qualified research professional and accept full responsibility for compliance with all relevant laws in your jurisdiction.
GHRP-6
Growth Hormone Releasing Peptide-6
GHRP-6 (His-D-Trp-Ala-Trp-D-Phe-Lys-NH2) is a synthetic hexapeptide and the original GHS-R1a agonist, developed by Bowers et al. in the 1980s from enkephalin structural research. It is the founding member of the GHRP family and remains a reference standard for GHS-R1a pharmacology. Alongside significant GH release, it produces pronounced appetite stimulation — the most marked of the GHRP class.
GHRP-6 activates GHS-R1a on pituitary somatotrophs (GH release) and on arcuate nucleus neurons (orexigenic appetite stimulation via NPY/AgRP pathway upregulation). The strong appetite stimulation is mediated through hypothalamic ghrelin receptors in a manner analogous to endogenous ghrelin, making GHRP-6 both a GH secretagogue and a potent stimulant of food intake. Cortisol and prolactin stimulation is intermediate between GHRP-2 and Ipamorelin.
GH secretagogue pharmacology, appetite and food intake research, cachexia and anorexia models (where appetite stimulation is desirable), ghrelin axis biology, body composition, and GH-axis stimulation protocols. Gastric protection studies have shown GHRP-6 (like BPC-157) has direct gastroprotective effects, independently of its GH-releasing activity.
For research reference only. All information pertains to preclinical or published human trial data. Not intended as medical advice. This product is for research use only.
Don't have supplies? Grab them while you're here.
